Telemetry Investments’s Bristol-Myers Squibb BMY Stock Holding History

Telemetry Investments’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-3,800	Closed	-$229K	–	91
2020 Q3	$229K	Buy	+3,800	New	+$229K	0.5%	59
2019 Q2	–	Sell	-6,300	Closed	-$301K	–	88
2019 Q1	$301K	Buy	+6,300	New	+$314K	0.15%	64
2015 Q2	–	Sell	-5,550	Closed	-$358K	–	176
2015 Q1	$358K	Buy	5,550 +550	+11%	+$34.4K	0.2%	99
2014 Q4	$295K	Buy	+5,000	New	+$282K	0.18%	124

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Telemetry Investments's BMY Position: Q4 2020 in Review

Telemetry Investments sold out of Bristol-Myers Squibb (BMY) in Q4 2020, closing a stake of 3,800 shares — an estimated $229K sold.

Telemetry Investments first reported a position in BMY in Q4 2014 and held it in 4 quarters. The position peaked at $358K in Q1 2015. 2,361 funds tracked by Wall St. Rank hold BMY as of Q4 2020.

Telemetry Investments reported no remaining Bristol-Myers Squibb position as of Q4 2020 after selling out during the quarter.
Telemetry Investments sold 3,800 Bristol-Myers Squibb shares in Q4 2020, an estimated $229K.
Telemetry Investments first reported a position in Bristol-Myers Squibb in Q4 2014 and held it in 4 quarters.
Telemetry Investments's Bristol-Myers Squibb position peaked at $358K in Q1 2015.
2,361 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2020.

Based on Telemetry Investments's 13F filing for Q4 2020, filed 16 Feb 2021.